Miltefosine (Impavido®) in the treatment of mucocutaneous and cutaneous leishmaniasis in Bolivia

被引：0
|
作者：
Toledo, Julia
Soto, Jaime
Soto, Paula
Balderama, Margarita
Rea, Ivan
Gomez, Ana
Soto, Jaime
Parra, Rolando
Valda, Luis
Guillen, Ninoshtka
Anders, Gerlind
Sindermann, Herbert
Engel, Jurgen
Berman, Jonathan
机构：
[1] Consorcio Invest Bioclin, Bogota, Colombia
[2] Proyecto OSCAR, Palos Blancos, Bolivia
[3] Hosp Palos Blancos, Palos Blancos, Bolivia
[4] Hosp Clin, La Paz, Bolivia
[5] Zentaris, Frankfurt, Germany
[6] Natl Ctr Complementary Alternative Med, Natl Inst Hlth, Bethesda, MD USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2006年 / 75卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1031
引用
收藏
页码：297 / 297
页数：1
相关论文
共 50 条
  • [1] Efficacy of miltefosine (Impavido®) for mucocutaneous leishmaniasis in Bolivia
    Soto, Jaime
    Toledo, Julia
    Parra, Rolando
    Balderrama, Margarita
    Rea, Jaime
    Gomez, Ana
    Ardiles, Jaime
    Soto, Paula
    Valda, Luis
    Sindermann, Herbert
    Anders, Gerlind
    Engel, Jurgen
    Berman, Jonathan
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 346 - 346
  • [2] Efficacy of miltefosine (Impavido®) for cutaneous leishmaniasis in Colombia
    Soto, Jaime
    Toledo, Julia
    Soto, Paula
    Padilla, Julio
    Sindermann, Herbert
    Anders, Gerlind
    Engel, Jurgen
    Berman, Jonathan
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 73 - 74
  • [3] Miltefosine (Impavido) for Leishmaniasis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1451): : 89 - 90
  • [4] Miltefosine (Impavido): the first oral treatment against leishmaniasis
    H. Sindermann
    S. L. Croft
    K. R. Engel
    W. Bommer
    H. J. Eibl
    C. Unger
    J. Engel
    [J]. Medical Microbiology and Immunology, 2004, 193 : 173 - 180
  • [5] Miltefosine (Impavido): the first oral treatment against leishmaniasis
    Sindermann, H
    Croft, SL
    Engel, KR
    Bommer, W
    Eibl, HJ
    Unger, C
    Engel, J
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2004, 193 (04) : 173 - 180
  • [6] IMPAVIDO™ (MILTEFOSINE) FOR ANNERGIC DIFFUSE CUTANEOUS LEISHMANIASIS, A RARE AND INTRACTABLE DISEASE
    Hueb, M.
    Oliveira, T. F.
    Grigoli, E.
    Viana, T. R.
    Proenca, W. B.
    Damin, B. C.
    Fonseca-Jr, E. A.
    Carvalho, A. P.
    Cavalcante, L. R. S.
    Reis, P., V
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 : S154 - S154
  • [7] Miltefosine Treatment of Cutaneous Leishmaniasis
    Soto, Jaime A.
    Berman, Jonathan D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2463 - E2464
  • [8] Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia
    Alcais, A
    Abel, L
    David, C
    Torrez, ME
    Flandre, P
    Dedet, JP
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 57 (01): : 79 - 84
  • [9] TREATMENT OF CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS
    BLUM, J
    JUNGHANSS, T
    HATZ, C
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 119 (34-35) : 1169 - 1172
  • [10] Impavido® (INN: miltefosine) -: first oral therapy of leishmaniasis
    不详
    [J]. INFECTION, 2005, 33 (03) : 181 - 182
12345